Ovid Therapeutics Inc.
OVIDNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $174.75M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.18$3.11
- Volume (live)
- -
- Avg. volume (3M)
- 1.86M
Ovid Therapeutics (OVID) Stock Price & Financial Analysis
Ovid Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.34 - $2.50 |
|---|---|
| 52-Week High | $3.11 |
| 52-Week Low | $1.18 |
| Open | $2.45 |
| Volume (last close) | 1.18M |
| Average Volume (3M) | 1.86M |
| Revenue (TTM) | 1.58M |
|---|---|
| Net Income (TTM) | -34.49M |
| Free Cash Flow (TTM) | -54.77M |
| EPS (TTM) | −$0.46 |
| Profit Margin | -2178.90% |
| Operating Margin | -3686.67% |
| Return on Equity (ROE) | -16.43% |
| Debt to Equity | 0.06 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 174.75M |
|---|---|
| Shares Outstanding | 73.74M |
| Price to Sales (P/S) | 110.39 |
| Price to Book (P/B) | 0.83 |
| EV/EBITDA | -3.04 |
| 50-Day MA | $2.60 |
|---|---|
| 200-Day MA | $2.34 |
| 1-Year Change | +51.92% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Ovid Therapeutics at a Glance
As of the Oct 22, 2026 close, Ovid Therapeutics (OVID) has a market capitalization of $174.75M. The stock trades at 110.4× sales. Over the trailing twelve months it lost $34.49M on revenue of $1.58M and burned $54.77M of free cash flow. Revenue fell 76.2% year over year.
As of its latest reported balance sheet, it holds $11.33M in cash and securities against $12.71M of debt, a net debt position of $1.39M.
Ovid Therapeutics does not currently pay a dividend.
The share price is up 51.9% over the past year. At $2.37 (the Oct 22, 2026 close) it sits within its 52-week range of $1.18 to $3.10, above its 200-day moving average of $2.34.
Based on 10 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $6.57, 177.2% above the Oct 22, 2026 close.
Frequently Asked Questions About Ovid Therapeutics
What is the current stock price for OVID?
As of the Oct 22, 2026 close, OVID stock trades at $2.37. The 52-week range is $1.18–$3.11, with a day range of $2.34–$2.50.
What is the P/E ratio for OVID?
The P/E ratio (Price-to-Earnings) for OVID is shown in the Key Statistics section. This valuation metric helps compare Ovid Therapeutics Inc. to industry peers.
Does OVID pay dividends?
Ovid Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for OVID?
Based on ratings from 10 professional analysts over the last 90 days, the consensus for OVID is Buy. The average 12-month price target is $6.57, a 177.2% upside from the Oct 22, 2026 close of $2.37.
What is the market cap of OVID?
As of the Oct 22, 2026 close, Ovid Therapeutics's market capitalization is $174.8M, classifying it as a micro-cap company. Ovid Therapeutics operates in the Healthcare sector within the Biotechnology industry.